Dysregulation of this pathway has significant implications in MGO-associated diseases, including diabetes, where JAK/STAT activation contributes to insulin resistance; cardiovascular disease, where it promotes vascular inflammation and atherosclerosis; and cancer, where it may facilitate the tumor microenvironment and tumor progression [217,218,219]. This evidence concerns the gene SOAT1 and neoplasm.